Gastrointestinal Cancer
Filters
Tafinlar (Dabrafenib) 75mg Capsules | BRAF Inhibitor | Novartis Hong Kong | GLT
Novartis's selective BRAF inhibitor for BRAF V600-mutated melanoma and NSCLC, supplied for Hong Kong.
Tafinlar (Dabrafenib) 75mg Capsules | BRAF Inhibitor | Novartis Switzerland | GLT
Novartis's selective BRAF inhibitor for BRAF V600-mutated melanoma and NSCLC, supplied for Switzerland.
RAFINLAR (Dabrafenib) 50mg Capsules | BRAF Inhibitor | Novartis India | GLT
Novartis's selective BRAF inhibitor for BRAF V600-mutated melanoma and NSCLC, supplied for India.
PHODABRA (Dabrafenib) 75mg | Generic BRAF Inhibitor | Pharma 2 Vientiane | GLT
Generic dabrafenib (BRAF inhibitor) by Pharma 2 Vientiane (Laos) — an affordable alternative to Tafinlar...
Dabradx (Dabrafenib) 75mg | Generic BRAF Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT
Generic dabrafenib (BRAF inhibitor) by BigBear Pharmaceutical Co., Ltd. (Laos) — an affordable alternative to...
LuciDabra (Dabrafenib) 75mg | Generic BRAF Inhibitor | Lucius Pharmaceuticals (Lao) Co., Ltd. | GLT
Generic dabrafenib (BRAF inhibitor) by Lucius Pharmaceuticals (Lao) Co., Ltd. (Laos) — an affordable alternative...
Pemazyre (Pemigatinib) 4.5/9/13.5mg | Incyte USA Originator | GLT
Incyte Corporation originator pemigatinib — first FDA-approved FGFR inhibitor for cholangiocarcinoma
Pemitini (Pemigatinib) 4.5mg*42 | TLPH Laos Generic | GLT
Trans Continental Life Science & Pharmaceuticals (TLPH) — pemigatinib 4.5mg generic, 42-tablet pack
Pemidx (Pemigatinib) 4.5mg*14 | BigBear Laos Generic | GLT
BigBear Pharmaceutical (Lao) — affordable pemigatinib 4.5mg generic for FGFR2 cholangiocarcinoma
LuciPem (Pemigatinib) 4.5mg*14 | Lucius Laos Generic | GLT
Lucius Pharmaceuticals (Lao) — pemigatinib 4.5mg generic for FGFR2 cholangiocarcinoma
Peminib (Pemigatinib) 13.5mg*14 | Ziska Bangladesh Generic | GLT
Ziska Pharmaceuticals Ltd. — pemigatinib 13.5mg generic for FGFR2 cholangiocarcinoma
Tibsovo (Ivosidenib) 250mg Tablets — IDH1 Inhibitor for AML & Cholangiocarcinoma | USA | GLT
US FDA-approved originator ivosidenib by Servier for IDH1-mutated AML and cholangiocarcinoma
Aivodx (Ivosidenib) 250mg Tablets — IDH1 Inhibitor Generic for AML | Laos | GLT
BigBear generic ivosidenib (IDH1 inhibitor) 250mg, 30 tablets per bottle, Lao Reg. 12L1054/23
Tibsovo (Ivosidenib) 250mg Tablets — First-in-Class IDH1 Inhibitor for AML | China | GLT
China-approved originator ivosidenib (拓舒沃) for relapsed/refractory IDH1-mutated AML, licensed to Servier
LuciVos (Ivosidenib) 250mg Tablets — IDH1 Inhibitor Generic for AML | Laos | GLT
Lucius generic ivosidenib (IDH1 inhibitor) 250mg, 60 tablets per box
Ivonib (Ivosidenib) 250mg Tablets — IDH1 Inhibitor Generic for AML | Laos | GLT
TLPH Tongmeng generic ivosidenib (IDH1 inhibitor) 250mg, 60 film-coated tablets
Sorafenib (Nexavar) 200mg*60's | Bayer Germany Originator | GLT
Bayer originator sorafenib 200mg tablets for unresectable HCC, advanced RCC & radioiodine-refractory DTC — German-origin...
Sorafenib (Ailituo) 200mg*60's | CSPC Ouyi China Generic | GLT
Ailituo (艾力妥) — CSPC Ouyi China generic sorafenib 200mg tablets for HCC, RCC & radioiodine-refractory...
Sorafenib (Soranni) 200mg*56's | TLPH Laos Generic | GLT
Soranni — Trans Continental (TLPH) Laos generic sorafenib 200mg tablets for HCC, RCC & radioiodine-refractory...
Sorafenib (LuciSora) 200mg*120's | Lucius Laos Generic | GLT
LuciSora — Lucius Pharmaceuticals Laos generic sorafenib 200mg, 120-tablet monthly pack for HCC, RCC &...
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling